207 related articles for article (PubMed ID: 36128207)
41. Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy.
Wu W; Jiang XY; Zhang QL; Mo Y; Sun LZ; Chen SM
World J Pediatr; 2009 Aug; 5(3):211-5. PubMed ID: 19693466
[TBL] [Abstract][Full Text] [Related]
42. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
43. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway.
Song X; Shi J; Liu J; Liu Y; Yu Y; Qiu Y; Cao Z; Pan Y; Yuan X; Chu Y; Wu D
Mol Med; 2022 Jul; 28(1):80. PubMed ID: 35842576
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
46. Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-β/Smad signaling pathways in vivo and in vitro.
Yu Y; Hu D; Zhou Y; Xiang H; Liu B; Shen L; Long C; Liu X; Lin T; He D; Zhang Y; Xu T; Zhang D; Wei G
Eur J Pharmacol; 2020 Sep; 883():173343. PubMed ID: 32629029
[TBL] [Abstract][Full Text] [Related]
47. The role of transforming growth factor β1 /Smad pathway in Alzheimer's disease inflammation pathology.
Yang C; Xu P
Mol Biol Rep; 2023 Jan; 50(1):777-788. PubMed ID: 36319781
[TBL] [Abstract][Full Text] [Related]
48. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
[TBL] [Abstract][Full Text] [Related]
49. TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.
Kim SI; Choi ME
Kidney Res Clin Pract; 2012 Jun; 31(2):94-105. PubMed ID: 26889415
[TBL] [Abstract][Full Text] [Related]
50. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs.
Tang PM; Zhang YY; Mak TS; Tang PC; Huang XR; Lan HY
J Physiol; 2018 Aug; 596(16):3493-3503. PubMed ID: 29781524
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor (TGF) β
Mahmood MQ; Reid D; Ward C; Muller HK; Knight DA; Sohal SS; Walters EH
Respirology; 2017 Jan; 22(1):133-140. PubMed ID: 27614607
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
[TBL] [Abstract][Full Text] [Related]
54. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.
Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X
Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164
[TBL] [Abstract][Full Text] [Related]
55. SMAD proteins directly suppress
Kaur G; Li CG; Chantry A; Stayner C; Horsfield J; Eccles MR
Oncotarget; 2018 Jun; 9(42):26852-26867. PubMed ID: 29928489
[TBL] [Abstract][Full Text] [Related]
56. si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway.
Liu L; Chen G; Chen T; Shi W; Hu H; Song K; Huang R; Cai H; He Y
Stem Cell Res Ther; 2020 Nov; 11(1):479. PubMed ID: 33176855
[TBL] [Abstract][Full Text] [Related]
57. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
58. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.
Feng F; Li N; Cheng P; Zhang H; Wang H; Wang Y; Wang W
Biomed Pharmacother; 2020 Jan; 121():109586. PubMed ID: 31706104
[TBL] [Abstract][Full Text] [Related]
59. LIM and Cysteine-Rich Domains 1 Promotes Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition in Human Kidney 2 Cells.
Yu R; Wu Y; He P; Bai Y; Zhang Y; Bian X; Sun G; Zhang B
Lab Invest; 2023 Feb; 103(2):100016. PubMed ID: 37039151
[TBL] [Abstract][Full Text] [Related]
60. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway.
Sun Z; Ning Q; Li H; Hu T; Tang L; Wen Q; Shen L
J Recept Signal Transduct Res; 2022 Feb; 42(1):60-66. PubMed ID: 33167758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
